Glycated hemoglobin and risk of hypertension in the atherosclerosis risk in communities study

Julie K Bower1, Lawrence J Appel, Kunihiro Matsushita

  • 1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. jbower@jhsph.edu

Diabetes Care
|March 21, 2012
PubMed

Insights

Elevated glycated hemoglobin (HbA1c), even without diabetes, predicts future hypertension. This finding suggests HbA1c may partially explain the link between high blood sugar and cardiovascular disease risk.

Area of Science:

  • Cardiovascular Disease Epidemiology
  • Metabolic Syndrome Research

Background:

  • Diabetes and hypertension frequently co-occur, sharing common risk factors.
  • Hypertension is a known predictor of diabetes, but the reverse association requires further investigation.
  • Hyperglycemia may independently contribute to the development of hypertension.

Purpose of the Study:

  • To investigate the association between glycated hemoglobin (HbA1c) levels and the incidence of hypertension.
  • To determine if HbA1c predicts future hypertension in individuals without diagnosed diabetes.

Main Methods:

  • Prospective analysis of 9,603 middle-aged participants from the Atherosclerosis Risk in Communities Study.
  • Cox proportional hazards models used to assess the relationship between baseline HbA1c and incident hypertension.
  • Hypertension defined by self-report (up to 18 years) and clinic visit measurements (up to 9 years).

Main Results:

  • Higher baseline HbA1c levels were associated with increased hypertension risk in both diabetic and non-diabetic individuals.
  • Prediabetic HbA1c levels (5.7-6.4%) independently predicted incident self-reported hypertension (HR 1.14) and visit-detected hypertension (HR 1.17).
  • Significant associations were observed even in participants without a prior diabetes diagnosis.

Conclusions:

  • Elevated HbA1c levels, including those in the prediabetic range, are linked to a higher risk of developing hypertension.
  • The known association between HbA1c and cardiovascular events may be partly explained by its role in hypertension development.
  • HbA1c serves as a valuable biomarker for predicting hypertension risk, even in the absence of diagnosed diabetes.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...